glp-1/gip agonists Science Behind GLP 1 GIP and Glucagon Receptor for Obesity Research | News & Announcements The dual glucose-dependent insulinotropic polypeptide

Nonalcoholic fatty liver disease: Common questions and answers on diagnosis and management

As with GLP-1 medications for weight loss, Wegovy for heart disease should be paired with a balanced reduced calorie diet and increased physical activity

It could also reduce astrogliosis and microgliosis in the dentate gyrus region of the hippocampus, prevent the impairment of pro-opiomelanocortin and G-protein-coupled receptor 43 expression caused by T2D, and simultaneously increase the number of NeuN+ and GLP-1R neurons in the hippocampus [Reference de Paiva, da Silva, Mendona, de Souza and Peixoto53]

Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials

10.17219/acem/151695 [DOI] [PubMed] [Google Scholar] 22